{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P38398",
      "entity_text" : "BRCA1",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_1R13" ],
      "TissueType" : [ "tissuelist:TS-0595" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "NSCLC patients lacking the expression of ERCC1 and BRCA1 benefit more from adjuvant cisplatin based chemotherapy compared with patients that expressed either ERCC1 or BRCA1 [XREF_BIBR].",
  "reading_complete" : "2020-08-04T13:22:37Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:20:52Z",
  "trigger" : "expression",
  "evidence" : [ "expression of ERCC1 and BRCA1" ],
  "pmc_id" : "5248564",
  "score" : 0
}